About MedReleaf
MedReleaf is a company based in Markham (Canada) founded in 2013, and was acquired by Aurora Cannabis in May 2018. Medical cannabis products and services are provided to patients. MedReleaf has completed 1 acquisition, including MED Colombia. Its chief executive, as recorded, is Miguel Martin.
Company details
MedReleaf was founded in 2013 in Markham, Canada, within the medical cannabis sector. A range of products, including dried flower, oils, capsules, concentrates, vapes, edibles, topicals, and accessories, is offered to customers. A product finder tool is available to match selections with user experience and preferences. Services such as client care, veterans programs, and pricing options are provided. All offerings are vetted by medical cannabis experts.
- Headquarters Markham, Canada
- Stage Acquired
- Email••••••••
- Phone•••• ••••
- Website medreleaf.com
- Social LinkedIn X Facebook
- Acquired by Aurora Cannabis (May 2018)
- Latest Funding Round$132.5M (USD), Post-IPO
Jan 2018
- Investors
- Investments & Acquisitions
- Acquired byAurora Cannabis
(May 2018)
Funding Insights of MedReleaf
- Total Rounds 2
- Last Round Post-IPO — $132.5M
- First Round $92M
(Dec 2017)
All 2 funding rounds of MedReleaf with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2018 | $132.5M | Post-IPO | – | – | – |
| Dec 2017 | $92M | Post-IPO | – | – | – |
1 investors in total: 1 institutional.
Investors in MedReleaf
MedReleaf has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Aurora Cannabis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Medical marijuana is produced and distributed by Aurora Cannabis. | 2006 | auroramj.com | Edmonton, Canada |
Investor details for MedReleaf
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MedReleaf
1 people are tracked at MedReleaf (1 in leadership).
| Name | Role | Group |
|---|---|---|
Miguel Martin | CEO | Leadership |
Complete people profiles for MedReleaf
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MedReleaf
MedReleaf has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MED Colombia.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Flower, oil extracts, and edibles are branded and distributed. | medcolombia.com | 0 | Jul 2018 | $3.22M |
Complete acquisition details for MedReleaf
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of MedReleaf
5 dated milestones of MedReleaf across 5 years, from founding to its latest funding, stage changes and deals.
- Founded MedReleaf is founded.
- Funding First funding round of $92.0M.
- Funding Latest funding round, Post-IPO, of $132.5M.
- Exit Acquired by Aurora Cannabis.
- Acquisition Acquires MED Colombia.
Web traffic of MedReleaf
Websites that share an audience with MedReleaf (medreleaf.com).
Websites whose visitors overlap most with MedReleaf. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mettrum.com | 100% | View details | |||
smallcappower.com | smallcappower.com | 62% | #6,442,446 | – | |
tweed.com | tweed.com | 61% | – | ||
| stockhouse.com | 60% | 1.3M | #51,794 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MedReleaf
MedReleaf was founded in 2013 and raised its 1st funding round 4 years after it was founded.
MedReleaf is headquartered in Markham, Canada. It is registered at Markham, Ontario, Canada.
Miguel Martin is the CEO of MedReleaf, as recorded in our data.
MedReleaf was founded in 2013 in Markham, Canada, within the medical cannabis sector. A range of products, including dried flower, oils, capsules, concentrates, vapes, edibles, topicals, and accessories, is offered to customers. A product finder tool is available to match selections with user experience and preferences. Services such as client care, veterans programs, and pricing options are provided. All offerings are vetted by medical cannabis experts.
MedReleaf has made 1 acquisition, including MED Colombia.
MedReleaf has 1 investor. Key investors include Aurora Cannabis.
Yes. MedReleaf was acquired by Aurora Cannabis in May 2018.